+Follow
pzcl
No personal profile
4
Follow
1
Followers
0
Topic
0
Badge
Posts
Hot
pzcl
2021-06-26
US will have to print more money besides increasing tax.
Biden infrastructure plan means upside for two materials stocks, Jefferies says
pzcl
2021-06-26
Like me please
US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week
pzcl
2021-06-26
I like you you like me please
US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week
pzcl
2021-06-26
V good
Alibaba: Can BABA Get Back To $300? Yes, It Can
pzcl
2021-06-28
Interesting. Will monitor.
Top strategist opens her playbook for the year’s second half, sees market turbulence ahead
pzcl
2021-06-28
Interesting. Will check out these stocks.
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4087529928368140","uuid":"4087529928368140","gmtCreate":1624447364101,"gmtModify":1624447364101,"name":"pzcl","pinyin":"pzcl","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":4,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":127160237,"gmtCreate":1624840039729,"gmtModify":1703845777551,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"Interesting. Will check out these stocks.","listText":"Interesting. Will check out these stocks.","text":"Interesting. Will check out these stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127160237","repostId":"1111453668","repostType":4,"isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127189059,"gmtCreate":1624839648271,"gmtModify":1703845763714,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"Interesting. Will monitor.","listText":"Interesting. Will monitor.","text":"Interesting. Will monitor.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127189059","repostId":"1161764161","repostType":4,"repost":{"id":"1161764161","kind":"news","pubTimestamp":1624836456,"share":"https://ttm.financial/m/news/1161764161?lang=&edition=fundamental","pubTime":"2021-06-28 07:27","market":"us","language":"en","title":"Top strategist opens her playbook for the year’s second half, sees market turbulence ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1161764161","media":"CNBC","summary":"Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thu","content":"<p>Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday.</p>\n<p>Her strategy includes an overexposure to cyclicals, and she favors financials,energy,commodities,materials and industrials.</p>\n<p>\"We see the economic recovery continuing and being a tailwind for stocks,\" the firm's head of investment strategy told CNBC's \"Trading Nation\" on Friday.</p>\n<p>Unless this week sees a dramatic sell-off, the market will start the year's final six months around record highs.</p>\n<p>The S&P 500 just wrapped up its best week since February,closing at 4,280.70 — an all-time high. The Dow closed up 3.4% for the week, notching its best weekly performance since mid-March.</p>\n<p>The tech-heavy Nasdaq closed slightly lower on Friday. But it’s up 2.35% for the week.</p>\n<p>Shue is optimistic on the broader market, but she also predicts turbulence ahead.</p>\n<p>“We are expecting some perhaps consolidation, maybe a pullback from here,” said Shue, a CNBC contributor.</p>\n<p>Shue, who oversees $141.5 billion in assets, is neutral on growth stocks,particularly Big Tech. She views the group as a key part of a diversified portfolio. However, Shue would avoid getting too deep into the group because she expects a rising10-year Treasury note yield to act as a headwind. According to Shue, it should reach at least 2% over the next 12 months.</p>\n<p>‘It’s really important not to forget about technology’</p>\n<p>“Technology is really a long term story. So, it might have some challenges if our interest rate view pans out. But it’s such an integral part of the economy,” she noted. “It’s really important not to forget about technology even if there is perhaps some choppiness over the next few months.”</p>\n<p>Shue expects the record rally to moderate over the next six months. She sees low to mid-single percentage gains.</p>\n<p>“Every indication that we have so far in the economic data is that we are probably at or just beyond the peak pace of economic activity perhaps of this cycle,” said Shue. “We are moving into probably a deceleration phase.”</p>\n<p>Yet, Shue suggests that shouldn’t spook investors.</p>\n<p>“The deceleration may actually still be above trend growth for the U.S. and the global economy,” she said.</p>\n<p>For now, Shue is underweightconsumer staples,utilitiesandREITS, which are considered defensive plays.</p>\n<p>“It’s been a pretty incredible run over the past 12 months, and we have clearly been bouncing off of the bottom,” Shue said.</p>","source":"lsy1609915699154","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top strategist opens her playbook for the year’s second half, sees market turbulence ahead</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop strategist opens her playbook for the year’s second half, sees market turbulence ahead\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 07:27 GMT+8 <a href=https://www.cnbc.com/2021/06/27/top-strategist-opens-market-playbook-for-second-half-sees-turbulence.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday.\nHer strategy includes an overexposure to cyclicals, and she favors financials,energy,...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/27/top-strategist-opens-market-playbook-for-second-half-sees-turbulence.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/06/27/top-strategist-opens-market-playbook-for-second-half-sees-turbulence.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161764161","content_text":"Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday.\nHer strategy includes an overexposure to cyclicals, and she favors financials,energy,commodities,materials and industrials.\n\"We see the economic recovery continuing and being a tailwind for stocks,\" the firm's head of investment strategy told CNBC's \"Trading Nation\" on Friday.\nUnless this week sees a dramatic sell-off, the market will start the year's final six months around record highs.\nThe S&P 500 just wrapped up its best week since February,closing at 4,280.70 — an all-time high. The Dow closed up 3.4% for the week, notching its best weekly performance since mid-March.\nThe tech-heavy Nasdaq closed slightly lower on Friday. But it’s up 2.35% for the week.\nShue is optimistic on the broader market, but she also predicts turbulence ahead.\n“We are expecting some perhaps consolidation, maybe a pullback from here,” said Shue, a CNBC contributor.\nShue, who oversees $141.5 billion in assets, is neutral on growth stocks,particularly Big Tech. She views the group as a key part of a diversified portfolio. However, Shue would avoid getting too deep into the group because she expects a rising10-year Treasury note yield to act as a headwind. According to Shue, it should reach at least 2% over the next 12 months.\n‘It’s really important not to forget about technology’\n“Technology is really a long term story. So, it might have some challenges if our interest rate view pans out. But it’s such an integral part of the economy,” she noted. “It’s really important not to forget about technology even if there is perhaps some choppiness over the next few months.”\nShue expects the record rally to moderate over the next six months. She sees low to mid-single percentage gains.\n“Every indication that we have so far in the economic data is that we are probably at or just beyond the peak pace of economic activity perhaps of this cycle,” said Shue. “We are moving into probably a deceleration phase.”\nYet, Shue suggests that shouldn’t spook investors.\n“The deceleration may actually still be above trend growth for the U.S. and the global economy,” she said.\nFor now, Shue is underweightconsumer staples,utilitiesandREITS, which are considered defensive plays.\n“It’s been a pretty incredible run over the past 12 months, and we have clearly been bouncing off of the bottom,” Shue said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124022551,"gmtCreate":1624709838373,"gmtModify":1703843977299,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"US will have to print more money besides increasing tax. ","listText":"US will have to print more money besides increasing tax. ","text":"US will have to print more money besides increasing tax.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/124022551","repostId":"1162379867","repostType":4,"repost":{"id":"1162379867","kind":"news","pubTimestamp":1624667602,"share":"https://ttm.financial/m/news/1162379867?lang=&edition=fundamental","pubTime":"2021-06-26 08:33","market":"us","language":"en","title":"Biden infrastructure plan means upside for two materials stocks, Jefferies says","url":"https://stock-news.laohu8.com/highlight/detail?id=1162379867","media":"CNBC","summary":"An infrastructure agreement between the Biden administration and a bipartisan group of senators repr","content":"<div>\n<p>An infrastructure agreement between the Biden administration and a bipartisan group of senators represents a “big step forward” and a positive for two materials companies, according to Jefferies.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden infrastructure plan means upside for two materials stocks, Jefferies says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden infrastructure plan means upside for two materials stocks, Jefferies says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:33 GMT+8 <a href=https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An infrastructure agreement between the Biden administration and a bipartisan group of senators represents a “big step forward” and a positive for two materials companies, according to Jefferies.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VMC":"火神材料","MLM":"马丁-玛丽埃塔材料"},"source_url":"https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1162379867","content_text":"An infrastructure agreement between the Biden administration and a bipartisan group of senators represents a “big step forward” and a positive for two materials companies, according to Jefferies.\nGravel supplier Martin Marietta Materials and cement makerVulcan Materialsshould each see a pickup in sales if some version of a physical infrastructure bill is passed, analyst Philip Ng said on Friday.\nJefferies upgraded both stocks to buy ratings and hiked its price targets on both materials firms.\nWith the market wary about “peak earnings for cyclicals, we believe MLM & VMC are positioned to outperform from a potential infrastructure bill & recovery in” nonresidential construction, Ng wrote in a note.\nAfter weeks of negotiation, the White House and a centrist group of senators announced Thursday that they agreed upon a policy framework for a physical infrastructure bill.\nThe plan would spend $973 billion over five years, and $1.2 trillion if continued over eight years, on a package that would fund improvements to roads, bridges, and airports, as well as bolstered construction for waterways, electric vehicles and broadband.\n\nWhile the details of the plan are subject to change, early estimates of the infrastructure bill’s spending include a $109 billion increase for roads and bridges. That kind of expenditure, spread over five to eight years, could increase materials industry demand by 5% to 8% annually over that time period, Jefferies said.\nAnalyst Ng added that the equity of Vulcan and Martin Marietta looks especially attractive relative to other materials companies given their exposure to nonresidential construction.\nThe nonresidential industry “is showing green shoots, with MLM noting bidding activity & pricing inquiries for light commercial were picking up,” he wrote. “With 34-40% of MLM & VMC’s sales in nonres, they have great leverage to a recovery in commercial and could provide upside in 2H21 / 2022.”\nBoth stocks have already posted strong returns for 2021 as the U.S. economy climbs its way out of the Covid-19 pandemic: Vulcan is up 19.3% and Martin Marietta has gained 26.7% since January.\nStill, Jefferies sees more upside ahead with a price target of $424 a share for Martin Marietta and $207 a share for Vulcan. Those two price targets imply upside of 18% for each stock from Thursday’s close.\nVulcan was last seen up 0.97%, while Martin Marietta added 0.1% on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124029918,"gmtCreate":1624709252334,"gmtModify":1703843969110,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"Like me please","listText":"Like me please","text":"Like me please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/124029918","repostId":"1134306371","repostType":4,"repost":{"id":"1134306371","kind":"news","pubTimestamp":1624665868,"share":"https://ttm.financial/m/news/1134306371?lang=&edition=fundamental","pubTime":"2021-06-26 08:04","market":"us","language":"en","title":"US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1134306371","media":"Renaissance Capital","summary":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Dox","content":"<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network <b>Doximity</b>(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform <b>Soulgate</b>(SSR).</p>\n<p><b>Doximity</b> (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.</p>\n<p>The largest deal of the week, Chinese freight platform <b>Full Truck Alliance</b>(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.</p>\n<p>Integrated insurer <b>Bright Health Group</b>(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.</p>\n<p><b>Confluent</b>(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.</p>\n<p>Car wash brand <b>Mister Car Wash</b>(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.</p>\n<p>HR services provider <b>First Advantage</b>(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.</p>\n<p>Chinese grocery delivery platform <b>Missfresh</b>(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.</p>\n<p>Customer experience software provider <b>Sprinklr</b>(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.</p>\n<p>Gene editing biotech <b>Graphite Bio</b>(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.</p>\n<p>Oncology biotech <b>Monte Rosa Therapeutics</b>(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.</p>\n<p>Irish DMT biotech <b>GH Research</b>(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.</p>\n<p>Oncology biotech <b>Elevation Oncology</b>(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.</p>\n<p>Biopharmaceutical reagents provider <b>Alpha Teknova</b>(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.</p>\n<p><b>Miromatrix Medical</b> (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.</p>\n<p>Antibiotic biotech <b>Acurx Pharmaceuticals</b>(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.</p>\n<p>CBD products maker <b>Grove</b>(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.</p>\n<p>Four SPACs raised $520 million led by <b>FinTech Acquisition VI</b>(FTVIU), which raised $220 million.</p>\n<p><img src=\"https://static.tigerbbs.com/ddaee6ee8ea0594af65c20afe2b09fb2\" tg-width=\"1057\" tg-height=\"708\"><img src=\"https://static.tigerbbs.com/adbfd8143d6b3c07799a5b5568126eae\" tg-width=\"1059\" tg-height=\"498\"></p>\n<p>23 IPOs submitted initial filings. Chinese vaping brand <b>Aspire Global</b>(ASPG) plans to raise $161 million. Fitness franchise <b>F45 Training</b>(FXLV), luxury social club operator <b>Membership Collective</b>(MCG), soft drink maker <b>Zevia</b>(ZVIA), specialty insurer <b>Ryan Specialty Group</b>(RYAN), ocular medical device maker <b>Sight Sciences</b>(SGHT), Italy-based<b>Stevanato Group</b>(STVN), real estate manager <b>Bridge Investment Group</b>(BRDG), consumer banking platform <b>Blend Labs</b>(BLND), database developer<b>Couchbase</b>(BASE), interior design software provider <b>Manycore Tech</b>(KOOL), Chinese tutoring platform <b>Spark Education</b>(SPRK), oncology biotech <b>Vividion Therapeutics</b>(VVID), e-commerce platform <b>VTEX</b>(VTEX), digital marketing services provider <b>Gambling.com Group</b>(GAMB), bone marrow disease biotech <b>Imago BioSciences</b>(IMGO), French biotech <b>Dynacure</b>(DYCU), microbial testing device provider <b>Rapid Micro Biosystems</b>(RPID), legal software provider <b>CS Disco</b>(LAW), oncology biotechs <b>Erasca</b>(ERAS) and <b>Candel Therapeutics</b>(CADL), and fitness franchisor <b>Xponential Fitness</b>(XPOF) all filed to raise $100 million. Medical imaging software provider <b>Perspectum Group</b>(SCAN) filed to raise $75 million.</p>\n<p>10 SPACs submitted initial filings led by Sagansky and Sloan’s <b>Spinning Eagle Acquisition</b>(SPNGU), which plans to raise $2 billion.</p>\n<img src=\"https://static.tigerbbs.com/5405c3b71416d44598b8debbc72ba0c6\" tg-width=\"1059\" tg-height=\"707\">\n<img src=\"https://static.tigerbbs.com/7d74d7af7f2c5dced4672868bf036d03\" tg-width=\"1058\" tg-height=\"663\">\n<img src=\"https://static.tigerbbs.com/1e4854a0e989f2eb5923924d3cdf1083\" tg-width=\"1060\" tg-height=\"554\">\n<p>This past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>\n<table>\n <thead>\n <tr></tr>\n </thead>\n</table>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:04 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","FA":"First Advantage Corp.","GHRS":"GH Research PLC","DOCS":"Doximity, Inc.","TKNO":"Alpha Teknova, Inc.","CFLT":"Confluent, Inc.","GLUE":"Monte Rosa Therapeutics","ELEV":"Elevation Oncology, Inc.","ACXP":"Acurx Pharmaceuticals, LLC*","MCW":"Mister Car Wash, Inc.",".DJI":"道琼斯","CXM":"Sprinklr, Inc.","MF":"每日优鲜","YMM":"满帮",".IXIC":"NASDAQ Composite"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134306371","content_text":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate(SSR).\nDoximity (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.\nThe largest deal of the week, Chinese freight platform Full Truck Alliance(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.\nIntegrated insurer Bright Health Group(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.\nConfluent(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.\nCar wash brand Mister Car Wash(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.\nHR services provider First Advantage(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.\nChinese grocery delivery platform Missfresh(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.\nCustomer experience software provider Sprinklr(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.\nGene editing biotech Graphite Bio(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.\nOncology biotech Monte Rosa Therapeutics(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.\nIrish DMT biotech GH Research(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.\nOncology biotech Elevation Oncology(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.\nBiopharmaceutical reagents provider Alpha Teknova(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.\nMiromatrix Medical (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.\nCBD products maker Grove(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.\nFour SPACs raised $520 million led by FinTech Acquisition VI(FTVIU), which raised $220 million.\n\n23 IPOs submitted initial filings. Chinese vaping brand Aspire Global(ASPG) plans to raise $161 million. Fitness franchise F45 Training(FXLV), luxury social club operator Membership Collective(MCG), soft drink maker Zevia(ZVIA), specialty insurer Ryan Specialty Group(RYAN), ocular medical device maker Sight Sciences(SGHT), Italy-basedStevanato Group(STVN), real estate manager Bridge Investment Group(BRDG), consumer banking platform Blend Labs(BLND), database developerCouchbase(BASE), interior design software provider Manycore Tech(KOOL), Chinese tutoring platform Spark Education(SPRK), oncology biotech Vividion Therapeutics(VVID), e-commerce platform VTEX(VTEX), digital marketing services provider Gambling.com Group(GAMB), bone marrow disease biotech Imago BioSciences(IMGO), French biotech Dynacure(DYCU), microbial testing device provider Rapid Micro Biosystems(RPID), legal software provider CS Disco(LAW), oncology biotechs Erasca(ERAS) and Candel Therapeutics(CADL), and fitness franchisor Xponential Fitness(XPOF) all filed to raise $100 million. Medical imaging software provider Perspectum Group(SCAN) filed to raise $75 million.\n10 SPACs submitted initial filings led by Sagansky and Sloan’s Spinning Eagle Acquisition(SPNGU), which plans to raise $2 billion.\n\n\n\nThis past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124020741,"gmtCreate":1624709227283,"gmtModify":1703843968946,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"I like you you like me please","listText":"I like you you like me please","text":"I like you you like me please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/124020741","repostId":"1134306371","repostType":4,"repost":{"id":"1134306371","kind":"news","pubTimestamp":1624665868,"share":"https://ttm.financial/m/news/1134306371?lang=&edition=fundamental","pubTime":"2021-06-26 08:04","market":"us","language":"en","title":"US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1134306371","media":"Renaissance Capital","summary":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Dox","content":"<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network <b>Doximity</b>(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform <b>Soulgate</b>(SSR).</p>\n<p><b>Doximity</b> (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.</p>\n<p>The largest deal of the week, Chinese freight platform <b>Full Truck Alliance</b>(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.</p>\n<p>Integrated insurer <b>Bright Health Group</b>(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.</p>\n<p><b>Confluent</b>(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.</p>\n<p>Car wash brand <b>Mister Car Wash</b>(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.</p>\n<p>HR services provider <b>First Advantage</b>(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.</p>\n<p>Chinese grocery delivery platform <b>Missfresh</b>(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.</p>\n<p>Customer experience software provider <b>Sprinklr</b>(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.</p>\n<p>Gene editing biotech <b>Graphite Bio</b>(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.</p>\n<p>Oncology biotech <b>Monte Rosa Therapeutics</b>(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.</p>\n<p>Irish DMT biotech <b>GH Research</b>(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.</p>\n<p>Oncology biotech <b>Elevation Oncology</b>(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.</p>\n<p>Biopharmaceutical reagents provider <b>Alpha Teknova</b>(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.</p>\n<p><b>Miromatrix Medical</b> (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.</p>\n<p>Antibiotic biotech <b>Acurx Pharmaceuticals</b>(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.</p>\n<p>CBD products maker <b>Grove</b>(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.</p>\n<p>Four SPACs raised $520 million led by <b>FinTech Acquisition VI</b>(FTVIU), which raised $220 million.</p>\n<p><img src=\"https://static.tigerbbs.com/ddaee6ee8ea0594af65c20afe2b09fb2\" tg-width=\"1057\" tg-height=\"708\"><img src=\"https://static.tigerbbs.com/adbfd8143d6b3c07799a5b5568126eae\" tg-width=\"1059\" tg-height=\"498\"></p>\n<p>23 IPOs submitted initial filings. Chinese vaping brand <b>Aspire Global</b>(ASPG) plans to raise $161 million. Fitness franchise <b>F45 Training</b>(FXLV), luxury social club operator <b>Membership Collective</b>(MCG), soft drink maker <b>Zevia</b>(ZVIA), specialty insurer <b>Ryan Specialty Group</b>(RYAN), ocular medical device maker <b>Sight Sciences</b>(SGHT), Italy-based<b>Stevanato Group</b>(STVN), real estate manager <b>Bridge Investment Group</b>(BRDG), consumer banking platform <b>Blend Labs</b>(BLND), database developer<b>Couchbase</b>(BASE), interior design software provider <b>Manycore Tech</b>(KOOL), Chinese tutoring platform <b>Spark Education</b>(SPRK), oncology biotech <b>Vividion Therapeutics</b>(VVID), e-commerce platform <b>VTEX</b>(VTEX), digital marketing services provider <b>Gambling.com Group</b>(GAMB), bone marrow disease biotech <b>Imago BioSciences</b>(IMGO), French biotech <b>Dynacure</b>(DYCU), microbial testing device provider <b>Rapid Micro Biosystems</b>(RPID), legal software provider <b>CS Disco</b>(LAW), oncology biotechs <b>Erasca</b>(ERAS) and <b>Candel Therapeutics</b>(CADL), and fitness franchisor <b>Xponential Fitness</b>(XPOF) all filed to raise $100 million. Medical imaging software provider <b>Perspectum Group</b>(SCAN) filed to raise $75 million.</p>\n<p>10 SPACs submitted initial filings led by Sagansky and Sloan’s <b>Spinning Eagle Acquisition</b>(SPNGU), which plans to raise $2 billion.</p>\n<img src=\"https://static.tigerbbs.com/5405c3b71416d44598b8debbc72ba0c6\" tg-width=\"1059\" tg-height=\"707\">\n<img src=\"https://static.tigerbbs.com/7d74d7af7f2c5dced4672868bf036d03\" tg-width=\"1058\" tg-height=\"663\">\n<img src=\"https://static.tigerbbs.com/1e4854a0e989f2eb5923924d3cdf1083\" tg-width=\"1060\" tg-height=\"554\">\n<p>This past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>\n<table>\n <thead>\n <tr></tr>\n </thead>\n</table>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:04 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","FA":"First Advantage Corp.","GHRS":"GH Research PLC","DOCS":"Doximity, Inc.","TKNO":"Alpha Teknova, Inc.","CFLT":"Confluent, Inc.","GLUE":"Monte Rosa Therapeutics","ELEV":"Elevation Oncology, Inc.","ACXP":"Acurx Pharmaceuticals, LLC*","MCW":"Mister Car Wash, Inc.",".DJI":"道琼斯","CXM":"Sprinklr, Inc.","MF":"每日优鲜","YMM":"满帮",".IXIC":"NASDAQ Composite"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134306371","content_text":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate(SSR).\nDoximity (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.\nThe largest deal of the week, Chinese freight platform Full Truck Alliance(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.\nIntegrated insurer Bright Health Group(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.\nConfluent(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.\nCar wash brand Mister Car Wash(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.\nHR services provider First Advantage(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.\nChinese grocery delivery platform Missfresh(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.\nCustomer experience software provider Sprinklr(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.\nGene editing biotech Graphite Bio(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.\nOncology biotech Monte Rosa Therapeutics(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.\nIrish DMT biotech GH Research(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.\nOncology biotech Elevation Oncology(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.\nBiopharmaceutical reagents provider Alpha Teknova(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.\nMiromatrix Medical (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.\nCBD products maker Grove(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.\nFour SPACs raised $520 million led by FinTech Acquisition VI(FTVIU), which raised $220 million.\n\n23 IPOs submitted initial filings. Chinese vaping brand Aspire Global(ASPG) plans to raise $161 million. Fitness franchise F45 Training(FXLV), luxury social club operator Membership Collective(MCG), soft drink maker Zevia(ZVIA), specialty insurer Ryan Specialty Group(RYAN), ocular medical device maker Sight Sciences(SGHT), Italy-basedStevanato Group(STVN), real estate manager Bridge Investment Group(BRDG), consumer banking platform Blend Labs(BLND), database developerCouchbase(BASE), interior design software provider Manycore Tech(KOOL), Chinese tutoring platform Spark Education(SPRK), oncology biotech Vividion Therapeutics(VVID), e-commerce platform VTEX(VTEX), digital marketing services provider Gambling.com Group(GAMB), bone marrow disease biotech Imago BioSciences(IMGO), French biotech Dynacure(DYCU), microbial testing device provider Rapid Micro Biosystems(RPID), legal software provider CS Disco(LAW), oncology biotechs Erasca(ERAS) and Candel Therapeutics(CADL), and fitness franchisor Xponential Fitness(XPOF) all filed to raise $100 million. Medical imaging software provider Perspectum Group(SCAN) filed to raise $75 million.\n10 SPACs submitted initial filings led by Sagansky and Sloan’s Spinning Eagle Acquisition(SPNGU), which plans to raise $2 billion.\n\n\n\nThis past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124064787,"gmtCreate":1624709009849,"gmtModify":1703843966165,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"V good","listText":"V good","text":"V good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/124064787","repostId":"1164137597","repostType":4,"repost":{"id":"1164137597","kind":"news","pubTimestamp":1624671774,"share":"https://ttm.financial/m/news/1164137597?lang=&edition=fundamental","pubTime":"2021-06-26 09:42","market":"us","language":"en","title":"Alibaba: Can BABA Get Back To $300? Yes, It Can","url":"https://stock-news.laohu8.com/highlight/detail?id=1164137597","media":"seekingalpha","summary":"The recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.The Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.Alibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.Alibaba is the dominant force in cloud services in China which could become a significant revenue g","content":"<p><b>Summary</b></p>\n<ul>\n <li>The recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.</li>\n <li>The Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.</li>\n <li>Alibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.</li>\n <li>Alibaba is the dominant force in cloud services in China which could become a significant revenue growth machine as the economy expands.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/814b0a9a0d17977f43665e2eba205b1e\" tg-width=\"1536\" tg-height=\"1024\"><span>Andrew Braun/iStock Editorial via Getty Images</span></p>\n<p>Alibaba(NYSE:BABA)operates a printing press that keeps spitting out tens of billions from total revenue down to net income. Many companies faced adversity throughout the pandemic, and some are still recovering, but not BABA. Through the worst economic environment for businesses to navigate in recent times, BABA generated over $100 billion in revenue and $20 billion in net income during their recent fiscal year. While BABA didn't get the memo about businesses facing challenges amidst the pandemic, the market must not have read BABA's earnings report or crunched the numbers.</p>\n<p>There are two Chinese companies I am bullish on, and BABA is my biggest conviction for appreciation. BABA smashed through the $300 share price level at the end of October 2020, but shareholders have been left confused and disappointed since then. It looked like BABA would turn the corner after a horrible end to 2020 as shares appreciated from $222.36 from the close of 2020 to $270.83 in the middle of February 2021. Still, the markets had other plans, and all shares of BABA have done is disappoint shareholders. If you missed the BABA train, it's time to grab your tickets and climb aboard, and if you purchased BABA during its run to $300 or early 2021 rebound, it might be time to add to your holdings. BABA is going to experience tremendous tailwinds from China's population and economic growth over the next several years, and their printing press is going to need more ink.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/86da7b532f25f563d08490ddc43cbede\" tg-width=\"640\" tg-height=\"337\"><span>(Source: Alibaba)</span></p>\n<p><b>The Alibaba printing press is open for business, and it spits out billions</b></p>\n<p>How many companies can say their annual revenue through the pandemic exceeded $100 billion? The $100 billion revenue mark is a prestigious club that companies such as Facebook (FB),PepsiCo (PEP),Procter & Gamble (PG),Target (TGT), and Johnson & Johnson (JNJ) are not part of. BABA, on the other hand, witnessed its revenue increase by 52.11% and smash through $100 billion as they generated $109.47 billion in their recent fiscal year. For the year ending March 2019, BABA's revenue increased by $16.25 billion (40.74%) to $56.15 billion, then for the March 2020 fiscal year, revenue increased another $15.82 billion (28.17%) to $71.97 billion. BABA is in the same boat as Alphabet(NASDAQ:GOOG)(GOOGL), FB, and Amazon (AMZN) as they watched the pandemic push more people to go digital which accelerated their businesses. For BABA, the forced transition to digital helped them achieve $37.5 billion (52.11%) in additional revenue as they finished their March 2021 fiscal year with $109.47 billion in revenue.</p>\n<p>Since 2013 BABA has not had a year where their annual revenue increase didn't exceed 25% Year over Year (YoY). When you think about that as a growth rate, it's remarkable for a company of BABA's size as this isn't a company chasing its first billion-dollar revenue year. Over the past 5 fiscal years, BABA's annual revenue has increased by $93.8 billion (408.08%) at an average annual rate of 48.25%. Smaller companies considered growth companies would be jealous of these rates, while many large caps are probably envious.</p>\n<p>BABA isn't a one-trick pony that can only generate tens of billions in revenue. BABA can convert right down to the bottom line. Each year BABA has increased its YoY gross profit by a minimum of 10% since 2013. In 2016 BABA generated $10.35 billion in gross profit and, over the next 5 fiscal years, increased its annual gross profit by $34.84 billion (336.68%). BABA has also never fallen below a 40% gross profit margin, Warren Buffett's magic number, as he indicates in<i>Warren Buffett and the Interpretation of Financial Statements. On page 34 of the Kindle edition,it says:</i></p>\n<blockquote>\n As a very general rule (and there are exceptions): Companies with gross profit margins of 40% or better tend to be companies with some sort of durable competitive advantage. Companies with gross profit margins below 40% tend to be companies in highly competitive industries, where competition is hurting overall profit margins (there are exceptions here, too).\n</blockquote>\n<p>The gross profit margin is important for investors to evaluate because it reveals how much of a company's revenue goes directly to producing it and if they have a moat around their business. BABA's numbers indicate they have a sufficient moat around their business that is hard to penetrate. With close to a decade of generating over 40% in gross profit margins, investors can expect that BABA's moat will protect its business operations for years to come.</p>\n<p>Moving to the bottom line BABA does a great job at generating profits. In their most recent fiscal year, BABA generated $22.98 billion in net income, converting more than 1/5th (20.99%) of their revenue to pure profits. Since 2013 BABA has only had 1 year where net income decreases YoY. With that track record, many options open up for BABA in the future as their cash stockpile continues to increase.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/41a5e036f023fa4ced7666e06aa1de6b\" tg-width=\"640\" tg-height=\"444\"><span>(Source: Alibaba)</span></p>\n<p><b>Alibaba will continue to experience tailwinds as China's population and economy expands</b></p>\n<p>Alibaba achieved one billion annual active consumers globally in the fiscal year that ended in March 2021. BABA has 891 million consumers across China's retail marketplace, local consumer services and digital media and entertainment platforms, and approximately 240 million consumers outside China. BABA's annual active consumers in the China retail marketplaces were 811 million as it grew by 85 million YoY. BABA will focus on developing a digital commerce infrastructure that offers an upgraded consumer experience by seamlessly integrating online and offline. Through BABA's infrastructure, countless retailers have digitally transformed their businesses and created multiple retail formats that have enabled new consumption experiences by leveraging consumer insights and technology. BABA's ecosystem, supply chain, and diversified fulfillment services have facilitated an immense digital transformation. By investing in its infrastructure, BABA's customers can now leverage a full range of high-frequency fulfillment services that include on-demand delivery, same-or-next day delivery, and next-day pick-up services for a full range of consumable and physical products.</p>\n<p>BABA will continue to be one of the cornerstones that supports growth within China's economy, which is benefiting from the acceleration of digitalization in all aspects of life and work. China is projected to be the world's largest economy by 2028. The per-capita income in China is expected to grow by roughly 50% from 2020 to 2025.China's average economic growth has been projected to increase at a rate of 5.7% from 2021 to 2025, then slow to 4.5% from 2026 to 2030. As a result,China is on track to join the top 1/3rd of nations and overtake 56 countries in the per capita income rankings by 2025. By the end of 2022, McKinsey predicts that the middle class could expand to 550 million people which is larger than the entire U.S population.</p>\n<p>If the projections for China are correct, this should mean a windfall of cash lining BABA's coffers. It's a simple recipe; when people make more money, they tend to spend more money to enhance their lives and increase their standard of living. As BABA is a dominant force in China's retail sector, they stand to benefit from a growing economy and a larger middle class. At the end of next year, if China has anywhere close to 550 million individuals in the middle class, I believe BABA's revenue and profits will increase significantly. This trend can provide tailwinds throughout the decade for BABA, and eventually, the market will reward shareholders based on BABA's value proposition.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbde4a092d19118a2d16daabf5c027d7\" tg-width=\"640\" tg-height=\"463\"><span>(Source: Blomberg)</span></p>\n<p><b>Alibaba has tremendous growth prospects in Cloud as China continues its digitization</b></p>\n<p>Cloud computing has been red hot in the U.S. as the transition from on-prem to cloud has increased the technological capabilities for many organizations. As digitization progresses across the business landscape, cloud providers continue to increase revenue generated from their cloud segments within their overall revenue mix. For example, AWS, the cloud computing division from AMZN, generated $45.37 billion in 2020. Cloud continues to be an exciting sector because the digital transformation is far from being over. Hence, the prospects of new customers are enormous while reoccurring revenue is generated after the transition occurs.</p>\n<p>In China, cloud infrastructure services are still in the early innings as the entire spend was around $15 billion in 2020. In Q1 of 2021, cloud infrastructure services in China grew by 55% YoY as it reached $6 billion. China was the 2nd largest market behind the U.S, accounting for 14% of global investment, up from 12% in Q1 of 2020. With cloud spending and digitization in China increasing, this serves as a major runway for growth in Alibaba Cloud.</p>\n<p>As China's economy expands, businesses will need to become more efficient to support both operations and customer demands. Chinese companies will need to implement infrastructure that can support a digital age of the workforce while supporting cloud services used by consumers for consumption. If China passes the U.S. as the world's largest economy in the second half of this decade, the amount of growth needed in cloud services will be immense. BABA is already the leader in cloud infrastructure services in China as their 39.8% market share accounted for $2.39 billion of the $6 billion spent in Q1 2021. Over the previous 6 quarters, cloud infrastructure spending has increased by roughly $2.3 billion (76.67%) in China. Based on cloud's current trajectory, quarterly revenue is on track to double over the next 2 years, putting Q1 2023 revenue at $10.6 billion. If BABA has a 35% market share, their Q1 2023 would be $3.71 billion, placing their 2023 revenue for cloud at $14.84 billion without factoring in any growth in 2023. From a cloud aspect, China's future spending is very exciting, and BABA will be one of the major benefactors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1759b81ce463d503a165d901e2e50d7c\" tg-width=\"640\" tg-height=\"728\"><span>(Source: Canalys)</span></p>\n<p><b>Alibaba has stellar financial metrics and is undervalued compared to the U.S. tech conglomerates</b></p>\n<p>For this comparison, I am going to use AMZN and GOOGL as they have been establishing their dominance in the U.S. for more than a decade. First, here are the raw numbers for AMZN, BABA, and GOOGL:</p>\n<ul>\n <li>AMZN</li>\n <li>BABA</li>\n <li>GOOGL</li>\n</ul>\n<p>The market currently places a multiple of 17.03x on AMZN's equity compared to its market cap, while its revenue multiple is 4.2x. GOOGL has a multiple of 7.17x on its equity and 8.39x on its revenue compared to market cap. AMZN and GOOGL's market caps exceed $1.5 trillion, while BABA's sits at $575.57 billion. The market is placing a 3.5x multiple on BABA's equity and 5.26x on its revenue compared to the market cap. Thus, the market is severely discounting BABA's equity and revenue generation. BABA's equity is worth 28.58% of its market cap, while AMZN's equity is equivalent to 5.87%, and GOOGL's is 13.94% of its market cap. The current discount placed on BABA's equity could create an additional tailwind for shareholders in the future.</p>\n<p><b>Conclusion</b></p>\n<p>It's hard to dismiss the growth opportunities some companies in China are presenting, especially after the recent decline in share prices. However, I believe shares of BABA are currently undervalued based on their current financial metrics and growth rates. China's economy and the amount of capital allocated to cloud service infrastructure are expected to grow substantially over the years. These will create powerful tailwinds for BABA throughout this decade. As a result, I think shareholders have been allowed to establish a BABA or dollar cost average position at a discounted price. I plan on continuing to add shares to my position while the market is discounting BABA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Can BABA Get Back To $300? Yes, It Can</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Can BABA Get Back To $300? Yes, It Can\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 09:42 GMT+8 <a href=https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.\nThe Chinese economy is expected to become the world's largest economy by...</p>\n\n<a href=\"https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164137597","content_text":"Summary\n\nThe recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.\nThe Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.\nAlibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.\nAlibaba is the dominant force in cloud services in China which could become a significant revenue growth machine as the economy expands.\n\nAndrew Braun/iStock Editorial via Getty Images\nAlibaba(NYSE:BABA)operates a printing press that keeps spitting out tens of billions from total revenue down to net income. Many companies faced adversity throughout the pandemic, and some are still recovering, but not BABA. Through the worst economic environment for businesses to navigate in recent times, BABA generated over $100 billion in revenue and $20 billion in net income during their recent fiscal year. While BABA didn't get the memo about businesses facing challenges amidst the pandemic, the market must not have read BABA's earnings report or crunched the numbers.\nThere are two Chinese companies I am bullish on, and BABA is my biggest conviction for appreciation. BABA smashed through the $300 share price level at the end of October 2020, but shareholders have been left confused and disappointed since then. It looked like BABA would turn the corner after a horrible end to 2020 as shares appreciated from $222.36 from the close of 2020 to $270.83 in the middle of February 2021. Still, the markets had other plans, and all shares of BABA have done is disappoint shareholders. If you missed the BABA train, it's time to grab your tickets and climb aboard, and if you purchased BABA during its run to $300 or early 2021 rebound, it might be time to add to your holdings. BABA is going to experience tremendous tailwinds from China's population and economic growth over the next several years, and their printing press is going to need more ink.\n(Source: Alibaba)\nThe Alibaba printing press is open for business, and it spits out billions\nHow many companies can say their annual revenue through the pandemic exceeded $100 billion? The $100 billion revenue mark is a prestigious club that companies such as Facebook (FB),PepsiCo (PEP),Procter & Gamble (PG),Target (TGT), and Johnson & Johnson (JNJ) are not part of. BABA, on the other hand, witnessed its revenue increase by 52.11% and smash through $100 billion as they generated $109.47 billion in their recent fiscal year. For the year ending March 2019, BABA's revenue increased by $16.25 billion (40.74%) to $56.15 billion, then for the March 2020 fiscal year, revenue increased another $15.82 billion (28.17%) to $71.97 billion. BABA is in the same boat as Alphabet(NASDAQ:GOOG)(GOOGL), FB, and Amazon (AMZN) as they watched the pandemic push more people to go digital which accelerated their businesses. For BABA, the forced transition to digital helped them achieve $37.5 billion (52.11%) in additional revenue as they finished their March 2021 fiscal year with $109.47 billion in revenue.\nSince 2013 BABA has not had a year where their annual revenue increase didn't exceed 25% Year over Year (YoY). When you think about that as a growth rate, it's remarkable for a company of BABA's size as this isn't a company chasing its first billion-dollar revenue year. Over the past 5 fiscal years, BABA's annual revenue has increased by $93.8 billion (408.08%) at an average annual rate of 48.25%. Smaller companies considered growth companies would be jealous of these rates, while many large caps are probably envious.\nBABA isn't a one-trick pony that can only generate tens of billions in revenue. BABA can convert right down to the bottom line. Each year BABA has increased its YoY gross profit by a minimum of 10% since 2013. In 2016 BABA generated $10.35 billion in gross profit and, over the next 5 fiscal years, increased its annual gross profit by $34.84 billion (336.68%). BABA has also never fallen below a 40% gross profit margin, Warren Buffett's magic number, as he indicates inWarren Buffett and the Interpretation of Financial Statements. On page 34 of the Kindle edition,it says:\n\n As a very general rule (and there are exceptions): Companies with gross profit margins of 40% or better tend to be companies with some sort of durable competitive advantage. Companies with gross profit margins below 40% tend to be companies in highly competitive industries, where competition is hurting overall profit margins (there are exceptions here, too).\n\nThe gross profit margin is important for investors to evaluate because it reveals how much of a company's revenue goes directly to producing it and if they have a moat around their business. BABA's numbers indicate they have a sufficient moat around their business that is hard to penetrate. With close to a decade of generating over 40% in gross profit margins, investors can expect that BABA's moat will protect its business operations for years to come.\nMoving to the bottom line BABA does a great job at generating profits. In their most recent fiscal year, BABA generated $22.98 billion in net income, converting more than 1/5th (20.99%) of their revenue to pure profits. Since 2013 BABA has only had 1 year where net income decreases YoY. With that track record, many options open up for BABA in the future as their cash stockpile continues to increase.\n(Source: Alibaba)\nAlibaba will continue to experience tailwinds as China's population and economy expands\nAlibaba achieved one billion annual active consumers globally in the fiscal year that ended in March 2021. BABA has 891 million consumers across China's retail marketplace, local consumer services and digital media and entertainment platforms, and approximately 240 million consumers outside China. BABA's annual active consumers in the China retail marketplaces were 811 million as it grew by 85 million YoY. BABA will focus on developing a digital commerce infrastructure that offers an upgraded consumer experience by seamlessly integrating online and offline. Through BABA's infrastructure, countless retailers have digitally transformed their businesses and created multiple retail formats that have enabled new consumption experiences by leveraging consumer insights and technology. BABA's ecosystem, supply chain, and diversified fulfillment services have facilitated an immense digital transformation. By investing in its infrastructure, BABA's customers can now leverage a full range of high-frequency fulfillment services that include on-demand delivery, same-or-next day delivery, and next-day pick-up services for a full range of consumable and physical products.\nBABA will continue to be one of the cornerstones that supports growth within China's economy, which is benefiting from the acceleration of digitalization in all aspects of life and work. China is projected to be the world's largest economy by 2028. The per-capita income in China is expected to grow by roughly 50% from 2020 to 2025.China's average economic growth has been projected to increase at a rate of 5.7% from 2021 to 2025, then slow to 4.5% from 2026 to 2030. As a result,China is on track to join the top 1/3rd of nations and overtake 56 countries in the per capita income rankings by 2025. By the end of 2022, McKinsey predicts that the middle class could expand to 550 million people which is larger than the entire U.S population.\nIf the projections for China are correct, this should mean a windfall of cash lining BABA's coffers. It's a simple recipe; when people make more money, they tend to spend more money to enhance their lives and increase their standard of living. As BABA is a dominant force in China's retail sector, they stand to benefit from a growing economy and a larger middle class. At the end of next year, if China has anywhere close to 550 million individuals in the middle class, I believe BABA's revenue and profits will increase significantly. This trend can provide tailwinds throughout the decade for BABA, and eventually, the market will reward shareholders based on BABA's value proposition.\n(Source: Blomberg)\nAlibaba has tremendous growth prospects in Cloud as China continues its digitization\nCloud computing has been red hot in the U.S. as the transition from on-prem to cloud has increased the technological capabilities for many organizations. As digitization progresses across the business landscape, cloud providers continue to increase revenue generated from their cloud segments within their overall revenue mix. For example, AWS, the cloud computing division from AMZN, generated $45.37 billion in 2020. Cloud continues to be an exciting sector because the digital transformation is far from being over. Hence, the prospects of new customers are enormous while reoccurring revenue is generated after the transition occurs.\nIn China, cloud infrastructure services are still in the early innings as the entire spend was around $15 billion in 2020. In Q1 of 2021, cloud infrastructure services in China grew by 55% YoY as it reached $6 billion. China was the 2nd largest market behind the U.S, accounting for 14% of global investment, up from 12% in Q1 of 2020. With cloud spending and digitization in China increasing, this serves as a major runway for growth in Alibaba Cloud.\nAs China's economy expands, businesses will need to become more efficient to support both operations and customer demands. Chinese companies will need to implement infrastructure that can support a digital age of the workforce while supporting cloud services used by consumers for consumption. If China passes the U.S. as the world's largest economy in the second half of this decade, the amount of growth needed in cloud services will be immense. BABA is already the leader in cloud infrastructure services in China as their 39.8% market share accounted for $2.39 billion of the $6 billion spent in Q1 2021. Over the previous 6 quarters, cloud infrastructure spending has increased by roughly $2.3 billion (76.67%) in China. Based on cloud's current trajectory, quarterly revenue is on track to double over the next 2 years, putting Q1 2023 revenue at $10.6 billion. If BABA has a 35% market share, their Q1 2023 would be $3.71 billion, placing their 2023 revenue for cloud at $14.84 billion without factoring in any growth in 2023. From a cloud aspect, China's future spending is very exciting, and BABA will be one of the major benefactors.\n(Source: Canalys)\nAlibaba has stellar financial metrics and is undervalued compared to the U.S. tech conglomerates\nFor this comparison, I am going to use AMZN and GOOGL as they have been establishing their dominance in the U.S. for more than a decade. First, here are the raw numbers for AMZN, BABA, and GOOGL:\n\nAMZN\nBABA\nGOOGL\n\nThe market currently places a multiple of 17.03x on AMZN's equity compared to its market cap, while its revenue multiple is 4.2x. GOOGL has a multiple of 7.17x on its equity and 8.39x on its revenue compared to market cap. AMZN and GOOGL's market caps exceed $1.5 trillion, while BABA's sits at $575.57 billion. The market is placing a 3.5x multiple on BABA's equity and 5.26x on its revenue compared to the market cap. Thus, the market is severely discounting BABA's equity and revenue generation. BABA's equity is worth 28.58% of its market cap, while AMZN's equity is equivalent to 5.87%, and GOOGL's is 13.94% of its market cap. The current discount placed on BABA's equity could create an additional tailwind for shareholders in the future.\nConclusion\nIt's hard to dismiss the growth opportunities some companies in China are presenting, especially after the recent decline in share prices. However, I believe shares of BABA are currently undervalued based on their current financial metrics and growth rates. China's economy and the amount of capital allocated to cloud service infrastructure are expected to grow substantially over the years. These will create powerful tailwinds for BABA throughout this decade. As a result, I think shareholders have been allowed to establish a BABA or dollar cost average position at a discounted price. I plan on continuing to add shares to my position while the market is discounting BABA.","news_type":1},"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":124022551,"gmtCreate":1624709838373,"gmtModify":1703843977299,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"US will have to print more money besides increasing tax. ","listText":"US will have to print more money besides increasing tax. ","text":"US will have to print more money besides increasing tax.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/124022551","repostId":"1162379867","repostType":4,"repost":{"id":"1162379867","kind":"news","pubTimestamp":1624667602,"share":"https://ttm.financial/m/news/1162379867?lang=&edition=fundamental","pubTime":"2021-06-26 08:33","market":"us","language":"en","title":"Biden infrastructure plan means upside for two materials stocks, Jefferies says","url":"https://stock-news.laohu8.com/highlight/detail?id=1162379867","media":"CNBC","summary":"An infrastructure agreement between the Biden administration and a bipartisan group of senators repr","content":"<div>\n<p>An infrastructure agreement between the Biden administration and a bipartisan group of senators represents a “big step forward” and a positive for two materials companies, according to Jefferies.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden infrastructure plan means upside for two materials stocks, Jefferies says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden infrastructure plan means upside for two materials stocks, Jefferies says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:33 GMT+8 <a href=https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An infrastructure agreement between the Biden administration and a bipartisan group of senators represents a “big step forward” and a positive for two materials companies, according to Jefferies.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VMC":"火神材料","MLM":"马丁-玛丽埃塔材料"},"source_url":"https://www.cnbc.com/2021/06/25/biden-infrastructure-plan-means-upside-for-two-materials-stocks.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1162379867","content_text":"An infrastructure agreement between the Biden administration and a bipartisan group of senators represents a “big step forward” and a positive for two materials companies, according to Jefferies.\nGravel supplier Martin Marietta Materials and cement makerVulcan Materialsshould each see a pickup in sales if some version of a physical infrastructure bill is passed, analyst Philip Ng said on Friday.\nJefferies upgraded both stocks to buy ratings and hiked its price targets on both materials firms.\nWith the market wary about “peak earnings for cyclicals, we believe MLM & VMC are positioned to outperform from a potential infrastructure bill & recovery in” nonresidential construction, Ng wrote in a note.\nAfter weeks of negotiation, the White House and a centrist group of senators announced Thursday that they agreed upon a policy framework for a physical infrastructure bill.\nThe plan would spend $973 billion over five years, and $1.2 trillion if continued over eight years, on a package that would fund improvements to roads, bridges, and airports, as well as bolstered construction for waterways, electric vehicles and broadband.\n\nWhile the details of the plan are subject to change, early estimates of the infrastructure bill’s spending include a $109 billion increase for roads and bridges. That kind of expenditure, spread over five to eight years, could increase materials industry demand by 5% to 8% annually over that time period, Jefferies said.\nAnalyst Ng added that the equity of Vulcan and Martin Marietta looks especially attractive relative to other materials companies given their exposure to nonresidential construction.\nThe nonresidential industry “is showing green shoots, with MLM noting bidding activity & pricing inquiries for light commercial were picking up,” he wrote. “With 34-40% of MLM & VMC’s sales in nonres, they have great leverage to a recovery in commercial and could provide upside in 2H21 / 2022.”\nBoth stocks have already posted strong returns for 2021 as the U.S. economy climbs its way out of the Covid-19 pandemic: Vulcan is up 19.3% and Martin Marietta has gained 26.7% since January.\nStill, Jefferies sees more upside ahead with a price target of $424 a share for Martin Marietta and $207 a share for Vulcan. Those two price targets imply upside of 18% for each stock from Thursday’s close.\nVulcan was last seen up 0.97%, while Martin Marietta added 0.1% on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124029918,"gmtCreate":1624709252334,"gmtModify":1703843969110,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"Like me please","listText":"Like me please","text":"Like me please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/124029918","repostId":"1134306371","repostType":4,"repost":{"id":"1134306371","kind":"news","pubTimestamp":1624665868,"share":"https://ttm.financial/m/news/1134306371?lang=&edition=fundamental","pubTime":"2021-06-26 08:04","market":"us","language":"en","title":"US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1134306371","media":"Renaissance Capital","summary":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Dox","content":"<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network <b>Doximity</b>(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform <b>Soulgate</b>(SSR).</p>\n<p><b>Doximity</b> (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.</p>\n<p>The largest deal of the week, Chinese freight platform <b>Full Truck Alliance</b>(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.</p>\n<p>Integrated insurer <b>Bright Health Group</b>(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.</p>\n<p><b>Confluent</b>(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.</p>\n<p>Car wash brand <b>Mister Car Wash</b>(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.</p>\n<p>HR services provider <b>First Advantage</b>(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.</p>\n<p>Chinese grocery delivery platform <b>Missfresh</b>(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.</p>\n<p>Customer experience software provider <b>Sprinklr</b>(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.</p>\n<p>Gene editing biotech <b>Graphite Bio</b>(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.</p>\n<p>Oncology biotech <b>Monte Rosa Therapeutics</b>(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.</p>\n<p>Irish DMT biotech <b>GH Research</b>(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.</p>\n<p>Oncology biotech <b>Elevation Oncology</b>(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.</p>\n<p>Biopharmaceutical reagents provider <b>Alpha Teknova</b>(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.</p>\n<p><b>Miromatrix Medical</b> (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.</p>\n<p>Antibiotic biotech <b>Acurx Pharmaceuticals</b>(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.</p>\n<p>CBD products maker <b>Grove</b>(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.</p>\n<p>Four SPACs raised $520 million led by <b>FinTech Acquisition VI</b>(FTVIU), which raised $220 million.</p>\n<p><img src=\"https://static.tigerbbs.com/ddaee6ee8ea0594af65c20afe2b09fb2\" tg-width=\"1057\" tg-height=\"708\"><img src=\"https://static.tigerbbs.com/adbfd8143d6b3c07799a5b5568126eae\" tg-width=\"1059\" tg-height=\"498\"></p>\n<p>23 IPOs submitted initial filings. Chinese vaping brand <b>Aspire Global</b>(ASPG) plans to raise $161 million. Fitness franchise <b>F45 Training</b>(FXLV), luxury social club operator <b>Membership Collective</b>(MCG), soft drink maker <b>Zevia</b>(ZVIA), specialty insurer <b>Ryan Specialty Group</b>(RYAN), ocular medical device maker <b>Sight Sciences</b>(SGHT), Italy-based<b>Stevanato Group</b>(STVN), real estate manager <b>Bridge Investment Group</b>(BRDG), consumer banking platform <b>Blend Labs</b>(BLND), database developer<b>Couchbase</b>(BASE), interior design software provider <b>Manycore Tech</b>(KOOL), Chinese tutoring platform <b>Spark Education</b>(SPRK), oncology biotech <b>Vividion Therapeutics</b>(VVID), e-commerce platform <b>VTEX</b>(VTEX), digital marketing services provider <b>Gambling.com Group</b>(GAMB), bone marrow disease biotech <b>Imago BioSciences</b>(IMGO), French biotech <b>Dynacure</b>(DYCU), microbial testing device provider <b>Rapid Micro Biosystems</b>(RPID), legal software provider <b>CS Disco</b>(LAW), oncology biotechs <b>Erasca</b>(ERAS) and <b>Candel Therapeutics</b>(CADL), and fitness franchisor <b>Xponential Fitness</b>(XPOF) all filed to raise $100 million. Medical imaging software provider <b>Perspectum Group</b>(SCAN) filed to raise $75 million.</p>\n<p>10 SPACs submitted initial filings led by Sagansky and Sloan’s <b>Spinning Eagle Acquisition</b>(SPNGU), which plans to raise $2 billion.</p>\n<img src=\"https://static.tigerbbs.com/5405c3b71416d44598b8debbc72ba0c6\" tg-width=\"1059\" tg-height=\"707\">\n<img src=\"https://static.tigerbbs.com/7d74d7af7f2c5dced4672868bf036d03\" tg-width=\"1058\" tg-height=\"663\">\n<img src=\"https://static.tigerbbs.com/1e4854a0e989f2eb5923924d3cdf1083\" tg-width=\"1060\" tg-height=\"554\">\n<p>This past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>\n<table>\n <thead>\n <tr></tr>\n </thead>\n</table>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:04 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","FA":"First Advantage Corp.","GHRS":"GH Research PLC","DOCS":"Doximity, Inc.","TKNO":"Alpha Teknova, Inc.","CFLT":"Confluent, Inc.","GLUE":"Monte Rosa Therapeutics","ELEV":"Elevation Oncology, Inc.","ACXP":"Acurx Pharmaceuticals, LLC*","MCW":"Mister Car Wash, Inc.",".DJI":"道琼斯","CXM":"Sprinklr, Inc.","MF":"每日优鲜","YMM":"满帮",".IXIC":"NASDAQ Composite"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134306371","content_text":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate(SSR).\nDoximity (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.\nThe largest deal of the week, Chinese freight platform Full Truck Alliance(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.\nIntegrated insurer Bright Health Group(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.\nConfluent(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.\nCar wash brand Mister Car Wash(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.\nHR services provider First Advantage(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.\nChinese grocery delivery platform Missfresh(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.\nCustomer experience software provider Sprinklr(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.\nGene editing biotech Graphite Bio(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.\nOncology biotech Monte Rosa Therapeutics(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.\nIrish DMT biotech GH Research(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.\nOncology biotech Elevation Oncology(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.\nBiopharmaceutical reagents provider Alpha Teknova(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.\nMiromatrix Medical (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.\nCBD products maker Grove(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.\nFour SPACs raised $520 million led by FinTech Acquisition VI(FTVIU), which raised $220 million.\n\n23 IPOs submitted initial filings. Chinese vaping brand Aspire Global(ASPG) plans to raise $161 million. Fitness franchise F45 Training(FXLV), luxury social club operator Membership Collective(MCG), soft drink maker Zevia(ZVIA), specialty insurer Ryan Specialty Group(RYAN), ocular medical device maker Sight Sciences(SGHT), Italy-basedStevanato Group(STVN), real estate manager Bridge Investment Group(BRDG), consumer banking platform Blend Labs(BLND), database developerCouchbase(BASE), interior design software provider Manycore Tech(KOOL), Chinese tutoring platform Spark Education(SPRK), oncology biotech Vividion Therapeutics(VVID), e-commerce platform VTEX(VTEX), digital marketing services provider Gambling.com Group(GAMB), bone marrow disease biotech Imago BioSciences(IMGO), French biotech Dynacure(DYCU), microbial testing device provider Rapid Micro Biosystems(RPID), legal software provider CS Disco(LAW), oncology biotechs Erasca(ERAS) and Candel Therapeutics(CADL), and fitness franchisor Xponential Fitness(XPOF) all filed to raise $100 million. Medical imaging software provider Perspectum Group(SCAN) filed to raise $75 million.\n10 SPACs submitted initial filings led by Sagansky and Sloan’s Spinning Eagle Acquisition(SPNGU), which plans to raise $2 billion.\n\n\n\nThis past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124020741,"gmtCreate":1624709227283,"gmtModify":1703843968946,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"I like you you like me please","listText":"I like you you like me please","text":"I like you you like me please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/124020741","repostId":"1134306371","repostType":4,"repost":{"id":"1134306371","kind":"news","pubTimestamp":1624665868,"share":"https://ttm.financial/m/news/1134306371?lang=&edition=fundamental","pubTime":"2021-06-26 08:04","market":"us","language":"en","title":"US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1134306371","media":"Renaissance Capital","summary":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Dox","content":"<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network <b>Doximity</b>(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform <b>Soulgate</b>(SSR).</p>\n<p><b>Doximity</b> (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.</p>\n<p>The largest deal of the week, Chinese freight platform <b>Full Truck Alliance</b>(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.</p>\n<p>Integrated insurer <b>Bright Health Group</b>(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.</p>\n<p><b>Confluent</b>(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.</p>\n<p>Car wash brand <b>Mister Car Wash</b>(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.</p>\n<p>HR services provider <b>First Advantage</b>(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.</p>\n<p>Chinese grocery delivery platform <b>Missfresh</b>(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.</p>\n<p>Customer experience software provider <b>Sprinklr</b>(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.</p>\n<p>Gene editing biotech <b>Graphite Bio</b>(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.</p>\n<p>Oncology biotech <b>Monte Rosa Therapeutics</b>(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.</p>\n<p>Irish DMT biotech <b>GH Research</b>(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.</p>\n<p>Oncology biotech <b>Elevation Oncology</b>(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.</p>\n<p>Biopharmaceutical reagents provider <b>Alpha Teknova</b>(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.</p>\n<p><b>Miromatrix Medical</b> (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.</p>\n<p>Antibiotic biotech <b>Acurx Pharmaceuticals</b>(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.</p>\n<p>CBD products maker <b>Grove</b>(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.</p>\n<p>Four SPACs raised $520 million led by <b>FinTech Acquisition VI</b>(FTVIU), which raised $220 million.</p>\n<p><img src=\"https://static.tigerbbs.com/ddaee6ee8ea0594af65c20afe2b09fb2\" tg-width=\"1057\" tg-height=\"708\"><img src=\"https://static.tigerbbs.com/adbfd8143d6b3c07799a5b5568126eae\" tg-width=\"1059\" tg-height=\"498\"></p>\n<p>23 IPOs submitted initial filings. Chinese vaping brand <b>Aspire Global</b>(ASPG) plans to raise $161 million. Fitness franchise <b>F45 Training</b>(FXLV), luxury social club operator <b>Membership Collective</b>(MCG), soft drink maker <b>Zevia</b>(ZVIA), specialty insurer <b>Ryan Specialty Group</b>(RYAN), ocular medical device maker <b>Sight Sciences</b>(SGHT), Italy-based<b>Stevanato Group</b>(STVN), real estate manager <b>Bridge Investment Group</b>(BRDG), consumer banking platform <b>Blend Labs</b>(BLND), database developer<b>Couchbase</b>(BASE), interior design software provider <b>Manycore Tech</b>(KOOL), Chinese tutoring platform <b>Spark Education</b>(SPRK), oncology biotech <b>Vividion Therapeutics</b>(VVID), e-commerce platform <b>VTEX</b>(VTEX), digital marketing services provider <b>Gambling.com Group</b>(GAMB), bone marrow disease biotech <b>Imago BioSciences</b>(IMGO), French biotech <b>Dynacure</b>(DYCU), microbial testing device provider <b>Rapid Micro Biosystems</b>(RPID), legal software provider <b>CS Disco</b>(LAW), oncology biotechs <b>Erasca</b>(ERAS) and <b>Candel Therapeutics</b>(CADL), and fitness franchisor <b>Xponential Fitness</b>(XPOF) all filed to raise $100 million. Medical imaging software provider <b>Perspectum Group</b>(SCAN) filed to raise $75 million.</p>\n<p>10 SPACs submitted initial filings led by Sagansky and Sloan’s <b>Spinning Eagle Acquisition</b>(SPNGU), which plans to raise $2 billion.</p>\n<img src=\"https://static.tigerbbs.com/5405c3b71416d44598b8debbc72ba0c6\" tg-width=\"1059\" tg-height=\"707\">\n<img src=\"https://static.tigerbbs.com/7d74d7af7f2c5dced4672868bf036d03\" tg-width=\"1058\" tg-height=\"663\">\n<img src=\"https://static.tigerbbs.com/1e4854a0e989f2eb5923924d3cdf1083\" tg-width=\"1060\" tg-height=\"554\">\n<p>This past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>\n<table>\n <thead>\n <tr></tr>\n </thead>\n</table>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:04 GMT+8 <a href=https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","FA":"First Advantage Corp.","GHRS":"GH Research PLC","DOCS":"Doximity, Inc.","TKNO":"Alpha Teknova, Inc.","CFLT":"Confluent, Inc.","GLUE":"Monte Rosa Therapeutics","ELEV":"Elevation Oncology, Inc.","ACXP":"Acurx Pharmaceuticals, LLC*","MCW":"Mister Car Wash, Inc.",".DJI":"道琼斯","CXM":"Sprinklr, Inc.","MF":"每日优鲜","YMM":"满帮",".IXIC":"NASDAQ Composite"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134306371","content_text":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate(SSR).\nDoximity (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.\nThe largest deal of the week, Chinese freight platform Full Truck Alliance(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.\nIntegrated insurer Bright Health Group(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.\nConfluent(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.\nCar wash brand Mister Car Wash(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.\nHR services provider First Advantage(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.\nChinese grocery delivery platform Missfresh(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.\nCustomer experience software provider Sprinklr(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.\nGene editing biotech Graphite Bio(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.\nOncology biotech Monte Rosa Therapeutics(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.\nIrish DMT biotech GH Research(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.\nOncology biotech Elevation Oncology(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.\nBiopharmaceutical reagents provider Alpha Teknova(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.\nMiromatrix Medical (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.\nCBD products maker Grove(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.\nFour SPACs raised $520 million led by FinTech Acquisition VI(FTVIU), which raised $220 million.\n\n23 IPOs submitted initial filings. Chinese vaping brand Aspire Global(ASPG) plans to raise $161 million. Fitness franchise F45 Training(FXLV), luxury social club operator Membership Collective(MCG), soft drink maker Zevia(ZVIA), specialty insurer Ryan Specialty Group(RYAN), ocular medical device maker Sight Sciences(SGHT), Italy-basedStevanato Group(STVN), real estate manager Bridge Investment Group(BRDG), consumer banking platform Blend Labs(BLND), database developerCouchbase(BASE), interior design software provider Manycore Tech(KOOL), Chinese tutoring platform Spark Education(SPRK), oncology biotech Vividion Therapeutics(VVID), e-commerce platform VTEX(VTEX), digital marketing services provider Gambling.com Group(GAMB), bone marrow disease biotech Imago BioSciences(IMGO), French biotech Dynacure(DYCU), microbial testing device provider Rapid Micro Biosystems(RPID), legal software provider CS Disco(LAW), oncology biotechs Erasca(ERAS) and Candel Therapeutics(CADL), and fitness franchisor Xponential Fitness(XPOF) all filed to raise $100 million. Medical imaging software provider Perspectum Group(SCAN) filed to raise $75 million.\n10 SPACs submitted initial filings led by Sagansky and Sloan’s Spinning Eagle Acquisition(SPNGU), which plans to raise $2 billion.\n\n\n\nThis past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124064787,"gmtCreate":1624709009849,"gmtModify":1703843966165,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"V good","listText":"V good","text":"V good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/124064787","repostId":"1164137597","repostType":4,"repost":{"id":"1164137597","kind":"news","pubTimestamp":1624671774,"share":"https://ttm.financial/m/news/1164137597?lang=&edition=fundamental","pubTime":"2021-06-26 09:42","market":"us","language":"en","title":"Alibaba: Can BABA Get Back To $300? Yes, It Can","url":"https://stock-news.laohu8.com/highlight/detail?id=1164137597","media":"seekingalpha","summary":"The recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.The Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.Alibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.Alibaba is the dominant force in cloud services in China which could become a significant revenue g","content":"<p><b>Summary</b></p>\n<ul>\n <li>The recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.</li>\n <li>The Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.</li>\n <li>Alibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.</li>\n <li>Alibaba is the dominant force in cloud services in China which could become a significant revenue growth machine as the economy expands.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/814b0a9a0d17977f43665e2eba205b1e\" tg-width=\"1536\" tg-height=\"1024\"><span>Andrew Braun/iStock Editorial via Getty Images</span></p>\n<p>Alibaba(NYSE:BABA)operates a printing press that keeps spitting out tens of billions from total revenue down to net income. Many companies faced adversity throughout the pandemic, and some are still recovering, but not BABA. Through the worst economic environment for businesses to navigate in recent times, BABA generated over $100 billion in revenue and $20 billion in net income during their recent fiscal year. While BABA didn't get the memo about businesses facing challenges amidst the pandemic, the market must not have read BABA's earnings report or crunched the numbers.</p>\n<p>There are two Chinese companies I am bullish on, and BABA is my biggest conviction for appreciation. BABA smashed through the $300 share price level at the end of October 2020, but shareholders have been left confused and disappointed since then. It looked like BABA would turn the corner after a horrible end to 2020 as shares appreciated from $222.36 from the close of 2020 to $270.83 in the middle of February 2021. Still, the markets had other plans, and all shares of BABA have done is disappoint shareholders. If you missed the BABA train, it's time to grab your tickets and climb aboard, and if you purchased BABA during its run to $300 or early 2021 rebound, it might be time to add to your holdings. BABA is going to experience tremendous tailwinds from China's population and economic growth over the next several years, and their printing press is going to need more ink.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/86da7b532f25f563d08490ddc43cbede\" tg-width=\"640\" tg-height=\"337\"><span>(Source: Alibaba)</span></p>\n<p><b>The Alibaba printing press is open for business, and it spits out billions</b></p>\n<p>How many companies can say their annual revenue through the pandemic exceeded $100 billion? The $100 billion revenue mark is a prestigious club that companies such as Facebook (FB),PepsiCo (PEP),Procter & Gamble (PG),Target (TGT), and Johnson & Johnson (JNJ) are not part of. BABA, on the other hand, witnessed its revenue increase by 52.11% and smash through $100 billion as they generated $109.47 billion in their recent fiscal year. For the year ending March 2019, BABA's revenue increased by $16.25 billion (40.74%) to $56.15 billion, then for the March 2020 fiscal year, revenue increased another $15.82 billion (28.17%) to $71.97 billion. BABA is in the same boat as Alphabet(NASDAQ:GOOG)(GOOGL), FB, and Amazon (AMZN) as they watched the pandemic push more people to go digital which accelerated their businesses. For BABA, the forced transition to digital helped them achieve $37.5 billion (52.11%) in additional revenue as they finished their March 2021 fiscal year with $109.47 billion in revenue.</p>\n<p>Since 2013 BABA has not had a year where their annual revenue increase didn't exceed 25% Year over Year (YoY). When you think about that as a growth rate, it's remarkable for a company of BABA's size as this isn't a company chasing its first billion-dollar revenue year. Over the past 5 fiscal years, BABA's annual revenue has increased by $93.8 billion (408.08%) at an average annual rate of 48.25%. Smaller companies considered growth companies would be jealous of these rates, while many large caps are probably envious.</p>\n<p>BABA isn't a one-trick pony that can only generate tens of billions in revenue. BABA can convert right down to the bottom line. Each year BABA has increased its YoY gross profit by a minimum of 10% since 2013. In 2016 BABA generated $10.35 billion in gross profit and, over the next 5 fiscal years, increased its annual gross profit by $34.84 billion (336.68%). BABA has also never fallen below a 40% gross profit margin, Warren Buffett's magic number, as he indicates in<i>Warren Buffett and the Interpretation of Financial Statements. On page 34 of the Kindle edition,it says:</i></p>\n<blockquote>\n As a very general rule (and there are exceptions): Companies with gross profit margins of 40% or better tend to be companies with some sort of durable competitive advantage. Companies with gross profit margins below 40% tend to be companies in highly competitive industries, where competition is hurting overall profit margins (there are exceptions here, too).\n</blockquote>\n<p>The gross profit margin is important for investors to evaluate because it reveals how much of a company's revenue goes directly to producing it and if they have a moat around their business. BABA's numbers indicate they have a sufficient moat around their business that is hard to penetrate. With close to a decade of generating over 40% in gross profit margins, investors can expect that BABA's moat will protect its business operations for years to come.</p>\n<p>Moving to the bottom line BABA does a great job at generating profits. In their most recent fiscal year, BABA generated $22.98 billion in net income, converting more than 1/5th (20.99%) of their revenue to pure profits. Since 2013 BABA has only had 1 year where net income decreases YoY. With that track record, many options open up for BABA in the future as their cash stockpile continues to increase.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/41a5e036f023fa4ced7666e06aa1de6b\" tg-width=\"640\" tg-height=\"444\"><span>(Source: Alibaba)</span></p>\n<p><b>Alibaba will continue to experience tailwinds as China's population and economy expands</b></p>\n<p>Alibaba achieved one billion annual active consumers globally in the fiscal year that ended in March 2021. BABA has 891 million consumers across China's retail marketplace, local consumer services and digital media and entertainment platforms, and approximately 240 million consumers outside China. BABA's annual active consumers in the China retail marketplaces were 811 million as it grew by 85 million YoY. BABA will focus on developing a digital commerce infrastructure that offers an upgraded consumer experience by seamlessly integrating online and offline. Through BABA's infrastructure, countless retailers have digitally transformed their businesses and created multiple retail formats that have enabled new consumption experiences by leveraging consumer insights and technology. BABA's ecosystem, supply chain, and diversified fulfillment services have facilitated an immense digital transformation. By investing in its infrastructure, BABA's customers can now leverage a full range of high-frequency fulfillment services that include on-demand delivery, same-or-next day delivery, and next-day pick-up services for a full range of consumable and physical products.</p>\n<p>BABA will continue to be one of the cornerstones that supports growth within China's economy, which is benefiting from the acceleration of digitalization in all aspects of life and work. China is projected to be the world's largest economy by 2028. The per-capita income in China is expected to grow by roughly 50% from 2020 to 2025.China's average economic growth has been projected to increase at a rate of 5.7% from 2021 to 2025, then slow to 4.5% from 2026 to 2030. As a result,China is on track to join the top 1/3rd of nations and overtake 56 countries in the per capita income rankings by 2025. By the end of 2022, McKinsey predicts that the middle class could expand to 550 million people which is larger than the entire U.S population.</p>\n<p>If the projections for China are correct, this should mean a windfall of cash lining BABA's coffers. It's a simple recipe; when people make more money, they tend to spend more money to enhance their lives and increase their standard of living. As BABA is a dominant force in China's retail sector, they stand to benefit from a growing economy and a larger middle class. At the end of next year, if China has anywhere close to 550 million individuals in the middle class, I believe BABA's revenue and profits will increase significantly. This trend can provide tailwinds throughout the decade for BABA, and eventually, the market will reward shareholders based on BABA's value proposition.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbde4a092d19118a2d16daabf5c027d7\" tg-width=\"640\" tg-height=\"463\"><span>(Source: Blomberg)</span></p>\n<p><b>Alibaba has tremendous growth prospects in Cloud as China continues its digitization</b></p>\n<p>Cloud computing has been red hot in the U.S. as the transition from on-prem to cloud has increased the technological capabilities for many organizations. As digitization progresses across the business landscape, cloud providers continue to increase revenue generated from their cloud segments within their overall revenue mix. For example, AWS, the cloud computing division from AMZN, generated $45.37 billion in 2020. Cloud continues to be an exciting sector because the digital transformation is far from being over. Hence, the prospects of new customers are enormous while reoccurring revenue is generated after the transition occurs.</p>\n<p>In China, cloud infrastructure services are still in the early innings as the entire spend was around $15 billion in 2020. In Q1 of 2021, cloud infrastructure services in China grew by 55% YoY as it reached $6 billion. China was the 2nd largest market behind the U.S, accounting for 14% of global investment, up from 12% in Q1 of 2020. With cloud spending and digitization in China increasing, this serves as a major runway for growth in Alibaba Cloud.</p>\n<p>As China's economy expands, businesses will need to become more efficient to support both operations and customer demands. Chinese companies will need to implement infrastructure that can support a digital age of the workforce while supporting cloud services used by consumers for consumption. If China passes the U.S. as the world's largest economy in the second half of this decade, the amount of growth needed in cloud services will be immense. BABA is already the leader in cloud infrastructure services in China as their 39.8% market share accounted for $2.39 billion of the $6 billion spent in Q1 2021. Over the previous 6 quarters, cloud infrastructure spending has increased by roughly $2.3 billion (76.67%) in China. Based on cloud's current trajectory, quarterly revenue is on track to double over the next 2 years, putting Q1 2023 revenue at $10.6 billion. If BABA has a 35% market share, their Q1 2023 would be $3.71 billion, placing their 2023 revenue for cloud at $14.84 billion without factoring in any growth in 2023. From a cloud aspect, China's future spending is very exciting, and BABA will be one of the major benefactors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1759b81ce463d503a165d901e2e50d7c\" tg-width=\"640\" tg-height=\"728\"><span>(Source: Canalys)</span></p>\n<p><b>Alibaba has stellar financial metrics and is undervalued compared to the U.S. tech conglomerates</b></p>\n<p>For this comparison, I am going to use AMZN and GOOGL as they have been establishing their dominance in the U.S. for more than a decade. First, here are the raw numbers for AMZN, BABA, and GOOGL:</p>\n<ul>\n <li>AMZN</li>\n <li>BABA</li>\n <li>GOOGL</li>\n</ul>\n<p>The market currently places a multiple of 17.03x on AMZN's equity compared to its market cap, while its revenue multiple is 4.2x. GOOGL has a multiple of 7.17x on its equity and 8.39x on its revenue compared to market cap. AMZN and GOOGL's market caps exceed $1.5 trillion, while BABA's sits at $575.57 billion. The market is placing a 3.5x multiple on BABA's equity and 5.26x on its revenue compared to the market cap. Thus, the market is severely discounting BABA's equity and revenue generation. BABA's equity is worth 28.58% of its market cap, while AMZN's equity is equivalent to 5.87%, and GOOGL's is 13.94% of its market cap. The current discount placed on BABA's equity could create an additional tailwind for shareholders in the future.</p>\n<p><b>Conclusion</b></p>\n<p>It's hard to dismiss the growth opportunities some companies in China are presenting, especially after the recent decline in share prices. However, I believe shares of BABA are currently undervalued based on their current financial metrics and growth rates. China's economy and the amount of capital allocated to cloud service infrastructure are expected to grow substantially over the years. These will create powerful tailwinds for BABA throughout this decade. As a result, I think shareholders have been allowed to establish a BABA or dollar cost average position at a discounted price. I plan on continuing to add shares to my position while the market is discounting BABA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Can BABA Get Back To $300? Yes, It Can</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Can BABA Get Back To $300? Yes, It Can\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 09:42 GMT+8 <a href=https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.\nThe Chinese economy is expected to become the world's largest economy by...</p>\n\n<a href=\"https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164137597","content_text":"Summary\n\nThe recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.\nThe Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.\nAlibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.\nAlibaba is the dominant force in cloud services in China which could become a significant revenue growth machine as the economy expands.\n\nAndrew Braun/iStock Editorial via Getty Images\nAlibaba(NYSE:BABA)operates a printing press that keeps spitting out tens of billions from total revenue down to net income. Many companies faced adversity throughout the pandemic, and some are still recovering, but not BABA. Through the worst economic environment for businesses to navigate in recent times, BABA generated over $100 billion in revenue and $20 billion in net income during their recent fiscal year. While BABA didn't get the memo about businesses facing challenges amidst the pandemic, the market must not have read BABA's earnings report or crunched the numbers.\nThere are two Chinese companies I am bullish on, and BABA is my biggest conviction for appreciation. BABA smashed through the $300 share price level at the end of October 2020, but shareholders have been left confused and disappointed since then. It looked like BABA would turn the corner after a horrible end to 2020 as shares appreciated from $222.36 from the close of 2020 to $270.83 in the middle of February 2021. Still, the markets had other plans, and all shares of BABA have done is disappoint shareholders. If you missed the BABA train, it's time to grab your tickets and climb aboard, and if you purchased BABA during its run to $300 or early 2021 rebound, it might be time to add to your holdings. BABA is going to experience tremendous tailwinds from China's population and economic growth over the next several years, and their printing press is going to need more ink.\n(Source: Alibaba)\nThe Alibaba printing press is open for business, and it spits out billions\nHow many companies can say their annual revenue through the pandemic exceeded $100 billion? The $100 billion revenue mark is a prestigious club that companies such as Facebook (FB),PepsiCo (PEP),Procter & Gamble (PG),Target (TGT), and Johnson & Johnson (JNJ) are not part of. BABA, on the other hand, witnessed its revenue increase by 52.11% and smash through $100 billion as they generated $109.47 billion in their recent fiscal year. For the year ending March 2019, BABA's revenue increased by $16.25 billion (40.74%) to $56.15 billion, then for the March 2020 fiscal year, revenue increased another $15.82 billion (28.17%) to $71.97 billion. BABA is in the same boat as Alphabet(NASDAQ:GOOG)(GOOGL), FB, and Amazon (AMZN) as they watched the pandemic push more people to go digital which accelerated their businesses. For BABA, the forced transition to digital helped them achieve $37.5 billion (52.11%) in additional revenue as they finished their March 2021 fiscal year with $109.47 billion in revenue.\nSince 2013 BABA has not had a year where their annual revenue increase didn't exceed 25% Year over Year (YoY). When you think about that as a growth rate, it's remarkable for a company of BABA's size as this isn't a company chasing its first billion-dollar revenue year. Over the past 5 fiscal years, BABA's annual revenue has increased by $93.8 billion (408.08%) at an average annual rate of 48.25%. Smaller companies considered growth companies would be jealous of these rates, while many large caps are probably envious.\nBABA isn't a one-trick pony that can only generate tens of billions in revenue. BABA can convert right down to the bottom line. Each year BABA has increased its YoY gross profit by a minimum of 10% since 2013. In 2016 BABA generated $10.35 billion in gross profit and, over the next 5 fiscal years, increased its annual gross profit by $34.84 billion (336.68%). BABA has also never fallen below a 40% gross profit margin, Warren Buffett's magic number, as he indicates inWarren Buffett and the Interpretation of Financial Statements. On page 34 of the Kindle edition,it says:\n\n As a very general rule (and there are exceptions): Companies with gross profit margins of 40% or better tend to be companies with some sort of durable competitive advantage. Companies with gross profit margins below 40% tend to be companies in highly competitive industries, where competition is hurting overall profit margins (there are exceptions here, too).\n\nThe gross profit margin is important for investors to evaluate because it reveals how much of a company's revenue goes directly to producing it and if they have a moat around their business. BABA's numbers indicate they have a sufficient moat around their business that is hard to penetrate. With close to a decade of generating over 40% in gross profit margins, investors can expect that BABA's moat will protect its business operations for years to come.\nMoving to the bottom line BABA does a great job at generating profits. In their most recent fiscal year, BABA generated $22.98 billion in net income, converting more than 1/5th (20.99%) of their revenue to pure profits. Since 2013 BABA has only had 1 year where net income decreases YoY. With that track record, many options open up for BABA in the future as their cash stockpile continues to increase.\n(Source: Alibaba)\nAlibaba will continue to experience tailwinds as China's population and economy expands\nAlibaba achieved one billion annual active consumers globally in the fiscal year that ended in March 2021. BABA has 891 million consumers across China's retail marketplace, local consumer services and digital media and entertainment platforms, and approximately 240 million consumers outside China. BABA's annual active consumers in the China retail marketplaces were 811 million as it grew by 85 million YoY. BABA will focus on developing a digital commerce infrastructure that offers an upgraded consumer experience by seamlessly integrating online and offline. Through BABA's infrastructure, countless retailers have digitally transformed their businesses and created multiple retail formats that have enabled new consumption experiences by leveraging consumer insights and technology. BABA's ecosystem, supply chain, and diversified fulfillment services have facilitated an immense digital transformation. By investing in its infrastructure, BABA's customers can now leverage a full range of high-frequency fulfillment services that include on-demand delivery, same-or-next day delivery, and next-day pick-up services for a full range of consumable and physical products.\nBABA will continue to be one of the cornerstones that supports growth within China's economy, which is benefiting from the acceleration of digitalization in all aspects of life and work. China is projected to be the world's largest economy by 2028. The per-capita income in China is expected to grow by roughly 50% from 2020 to 2025.China's average economic growth has been projected to increase at a rate of 5.7% from 2021 to 2025, then slow to 4.5% from 2026 to 2030. As a result,China is on track to join the top 1/3rd of nations and overtake 56 countries in the per capita income rankings by 2025. By the end of 2022, McKinsey predicts that the middle class could expand to 550 million people which is larger than the entire U.S population.\nIf the projections for China are correct, this should mean a windfall of cash lining BABA's coffers. It's a simple recipe; when people make more money, they tend to spend more money to enhance their lives and increase their standard of living. As BABA is a dominant force in China's retail sector, they stand to benefit from a growing economy and a larger middle class. At the end of next year, if China has anywhere close to 550 million individuals in the middle class, I believe BABA's revenue and profits will increase significantly. This trend can provide tailwinds throughout the decade for BABA, and eventually, the market will reward shareholders based on BABA's value proposition.\n(Source: Blomberg)\nAlibaba has tremendous growth prospects in Cloud as China continues its digitization\nCloud computing has been red hot in the U.S. as the transition from on-prem to cloud has increased the technological capabilities for many organizations. As digitization progresses across the business landscape, cloud providers continue to increase revenue generated from their cloud segments within their overall revenue mix. For example, AWS, the cloud computing division from AMZN, generated $45.37 billion in 2020. Cloud continues to be an exciting sector because the digital transformation is far from being over. Hence, the prospects of new customers are enormous while reoccurring revenue is generated after the transition occurs.\nIn China, cloud infrastructure services are still in the early innings as the entire spend was around $15 billion in 2020. In Q1 of 2021, cloud infrastructure services in China grew by 55% YoY as it reached $6 billion. China was the 2nd largest market behind the U.S, accounting for 14% of global investment, up from 12% in Q1 of 2020. With cloud spending and digitization in China increasing, this serves as a major runway for growth in Alibaba Cloud.\nAs China's economy expands, businesses will need to become more efficient to support both operations and customer demands. Chinese companies will need to implement infrastructure that can support a digital age of the workforce while supporting cloud services used by consumers for consumption. If China passes the U.S. as the world's largest economy in the second half of this decade, the amount of growth needed in cloud services will be immense. BABA is already the leader in cloud infrastructure services in China as their 39.8% market share accounted for $2.39 billion of the $6 billion spent in Q1 2021. Over the previous 6 quarters, cloud infrastructure spending has increased by roughly $2.3 billion (76.67%) in China. Based on cloud's current trajectory, quarterly revenue is on track to double over the next 2 years, putting Q1 2023 revenue at $10.6 billion. If BABA has a 35% market share, their Q1 2023 would be $3.71 billion, placing their 2023 revenue for cloud at $14.84 billion without factoring in any growth in 2023. From a cloud aspect, China's future spending is very exciting, and BABA will be one of the major benefactors.\n(Source: Canalys)\nAlibaba has stellar financial metrics and is undervalued compared to the U.S. tech conglomerates\nFor this comparison, I am going to use AMZN and GOOGL as they have been establishing their dominance in the U.S. for more than a decade. First, here are the raw numbers for AMZN, BABA, and GOOGL:\n\nAMZN\nBABA\nGOOGL\n\nThe market currently places a multiple of 17.03x on AMZN's equity compared to its market cap, while its revenue multiple is 4.2x. GOOGL has a multiple of 7.17x on its equity and 8.39x on its revenue compared to market cap. AMZN and GOOGL's market caps exceed $1.5 trillion, while BABA's sits at $575.57 billion. The market is placing a 3.5x multiple on BABA's equity and 5.26x on its revenue compared to the market cap. Thus, the market is severely discounting BABA's equity and revenue generation. BABA's equity is worth 28.58% of its market cap, while AMZN's equity is equivalent to 5.87%, and GOOGL's is 13.94% of its market cap. The current discount placed on BABA's equity could create an additional tailwind for shareholders in the future.\nConclusion\nIt's hard to dismiss the growth opportunities some companies in China are presenting, especially after the recent decline in share prices. However, I believe shares of BABA are currently undervalued based on their current financial metrics and growth rates. China's economy and the amount of capital allocated to cloud service infrastructure are expected to grow substantially over the years. These will create powerful tailwinds for BABA throughout this decade. As a result, I think shareholders have been allowed to establish a BABA or dollar cost average position at a discounted price. I plan on continuing to add shares to my position while the market is discounting BABA.","news_type":1},"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127189059,"gmtCreate":1624839648271,"gmtModify":1703845763714,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"Interesting. Will monitor.","listText":"Interesting. Will monitor.","text":"Interesting. Will monitor.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127189059","repostId":"1161764161","repostType":4,"repost":{"id":"1161764161","kind":"news","pubTimestamp":1624836456,"share":"https://ttm.financial/m/news/1161764161?lang=&edition=fundamental","pubTime":"2021-06-28 07:27","market":"us","language":"en","title":"Top strategist opens her playbook for the year’s second half, sees market turbulence ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=1161764161","media":"CNBC","summary":"Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thu","content":"<p>Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday.</p>\n<p>Her strategy includes an overexposure to cyclicals, and she favors financials,energy,commodities,materials and industrials.</p>\n<p>\"We see the economic recovery continuing and being a tailwind for stocks,\" the firm's head of investment strategy told CNBC's \"Trading Nation\" on Friday.</p>\n<p>Unless this week sees a dramatic sell-off, the market will start the year's final six months around record highs.</p>\n<p>The S&P 500 just wrapped up its best week since February,closing at 4,280.70 — an all-time high. The Dow closed up 3.4% for the week, notching its best weekly performance since mid-March.</p>\n<p>The tech-heavy Nasdaq closed slightly lower on Friday. But it’s up 2.35% for the week.</p>\n<p>Shue is optimistic on the broader market, but she also predicts turbulence ahead.</p>\n<p>“We are expecting some perhaps consolidation, maybe a pullback from here,” said Shue, a CNBC contributor.</p>\n<p>Shue, who oversees $141.5 billion in assets, is neutral on growth stocks,particularly Big Tech. She views the group as a key part of a diversified portfolio. However, Shue would avoid getting too deep into the group because she expects a rising10-year Treasury note yield to act as a headwind. According to Shue, it should reach at least 2% over the next 12 months.</p>\n<p>‘It’s really important not to forget about technology’</p>\n<p>“Technology is really a long term story. So, it might have some challenges if our interest rate view pans out. But it’s such an integral part of the economy,” she noted. “It’s really important not to forget about technology even if there is perhaps some choppiness over the next few months.”</p>\n<p>Shue expects the record rally to moderate over the next six months. She sees low to mid-single percentage gains.</p>\n<p>“Every indication that we have so far in the economic data is that we are probably at or just beyond the peak pace of economic activity perhaps of this cycle,” said Shue. “We are moving into probably a deceleration phase.”</p>\n<p>Yet, Shue suggests that shouldn’t spook investors.</p>\n<p>“The deceleration may actually still be above trend growth for the U.S. and the global economy,” she said.</p>\n<p>For now, Shue is underweightconsumer staples,utilitiesandREITS, which are considered defensive plays.</p>\n<p>“It’s been a pretty incredible run over the past 12 months, and we have clearly been bouncing off of the bottom,” Shue said.</p>","source":"lsy1609915699154","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top strategist opens her playbook for the year’s second half, sees market turbulence ahead</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop strategist opens her playbook for the year’s second half, sees market turbulence ahead\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 07:27 GMT+8 <a href=https://www.cnbc.com/2021/06/27/top-strategist-opens-market-playbook-for-second-half-sees-turbulence.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday.\nHer strategy includes an overexposure to cyclicals, and she favors financials,energy,...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/27/top-strategist-opens-market-playbook-for-second-half-sees-turbulence.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/06/27/top-strategist-opens-market-playbook-for-second-half-sees-turbulence.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161764161","content_text":"Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday.\nHer strategy includes an overexposure to cyclicals, and she favors financials,energy,commodities,materials and industrials.\n\"We see the economic recovery continuing and being a tailwind for stocks,\" the firm's head of investment strategy told CNBC's \"Trading Nation\" on Friday.\nUnless this week sees a dramatic sell-off, the market will start the year's final six months around record highs.\nThe S&P 500 just wrapped up its best week since February,closing at 4,280.70 — an all-time high. The Dow closed up 3.4% for the week, notching its best weekly performance since mid-March.\nThe tech-heavy Nasdaq closed slightly lower on Friday. But it’s up 2.35% for the week.\nShue is optimistic on the broader market, but she also predicts turbulence ahead.\n“We are expecting some perhaps consolidation, maybe a pullback from here,” said Shue, a CNBC contributor.\nShue, who oversees $141.5 billion in assets, is neutral on growth stocks,particularly Big Tech. She views the group as a key part of a diversified portfolio. However, Shue would avoid getting too deep into the group because she expects a rising10-year Treasury note yield to act as a headwind. According to Shue, it should reach at least 2% over the next 12 months.\n‘It’s really important not to forget about technology’\n“Technology is really a long term story. So, it might have some challenges if our interest rate view pans out. But it’s such an integral part of the economy,” she noted. “It’s really important not to forget about technology even if there is perhaps some choppiness over the next few months.”\nShue expects the record rally to moderate over the next six months. She sees low to mid-single percentage gains.\n“Every indication that we have so far in the economic data is that we are probably at or just beyond the peak pace of economic activity perhaps of this cycle,” said Shue. “We are moving into probably a deceleration phase.”\nYet, Shue suggests that shouldn’t spook investors.\n“The deceleration may actually still be above trend growth for the U.S. and the global economy,” she said.\nFor now, Shue is underweightconsumer staples,utilitiesandREITS, which are considered defensive plays.\n“It’s been a pretty incredible run over the past 12 months, and we have clearly been bouncing off of the bottom,” Shue said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127160237,"gmtCreate":1624840039729,"gmtModify":1703845777551,"author":{"id":"4087529928368140","authorId":"4087529928368140","name":"pzcl","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087529928368140","authorIdStr":"4087529928368140"},"themes":[],"htmlText":"Interesting. Will check out these stocks.","listText":"Interesting. Will check out these stocks.","text":"Interesting. Will check out these stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127160237","repostId":"1111453668","repostType":4,"isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}